Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient
- PMID: 7641911
- DOI: 10.1016/s0015-0282(16)57793-0
Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient
Abstract
Objective: To evaluate the outcome of oocytes donated by women with polycystic ovarian syndrome (PCOS) compared with oocytes donated by women with mechanical infertility.
Design: A retrospective study.
Patients: The outcome of 159 oocyte donation cycles with oocyte donated by PCOS patients were compared with 69 oocyte donation cycles with oocytes donated by patients with mechanical infertility. We compared the stimulation protocols in the donors to assess if the combination of GnRH analogue (GnRH-a), FSH, and hMG has an advantage over FSH and hMG alone with respect to their effect on fertilization and implantation rates in oocyte donation cycles.
Results: When treated with GnRH-a, pregnancy rates in PCOS and mechanical infertility donors were higher than those treated with FSH and hMG alone. The comparison between PCOS and mechanical factor oocyte recipients revealed no significant difference in the pregnancy and abortion rates, but the oocytes of patients with PCOS that were exposed to GnRH-a had a significantly higher implantation rate than those not exposed to GnRH-a.
Conclusions: Oocytes obtained from PCOS patients had a fertilization potential equal to oocytes obtained from mechanical infertility donors. Furthermore, because the oocytes of patients with PCOS exposed to GnRH-a had a significantly higher implantation rate, a detrimental role of high LH on oocyte quality seems probable. However, because PCOS has a high familial prevalence, some reservations may arise due to a possible propagation of the problem in the next generation of oocyte donation programs.
Similar articles
-
The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.Medicine (Baltimore). 2016 Jul;95(28):e4193. doi: 10.1097/MD.0000000000004193. Medicine (Baltimore). 2016. PMID: 27428219 Free PMC article.
-
Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization.Fertil Steril. 1996 Jan;65(1):1-10. doi: 10.1016/s0015-0282(16)58017-0. Fertil Steril. 1996. PMID: 8557121 Review.
-
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25. Fertil Steril. 2009. PMID: 18367175
-
What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?Fertil Steril. 2009 Apr;91(4 Suppl):1466-8. doi: 10.1016/j.fertnstert.2008.07.1711. Epub 2008 Sep 6. Fertil Steril. 2009. PMID: 18774558
-
[Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].Ceska Gynekol. 2018 Winter;83(1):11-16. Ceska Gynekol. 2018. PMID: 29510633 Review. Czech.
Cited by
-
Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome.Front Pharmacol. 2022 Jul 25;13:904942. doi: 10.3389/fphar.2022.904942. eCollection 2022. Front Pharmacol. 2022. PMID: 35959444 Free PMC article. Review.
-
Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins.Front Endocrinol (Lausanne). 2022 Jul 14;13:871945. doi: 10.3389/fendo.2022.871945. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909514 Free PMC article.
-
Among high responders, is oocyte development potential different in Rotterdam consensus PCOS vs non-PCOS patients undergoing IVF?J Assist Reprod Genet. 2022 Oct;39(10):2311-2316. doi: 10.1007/s10815-022-02598-7. Epub 2022 Aug 27. J Assist Reprod Genet. 2022. PMID: 36029372 Free PMC article.
-
Basic aspects of endometrial receptivity in PCOS patients.Mol Biol Rep. 2022 Feb;49(2):1519-1528. doi: 10.1007/s11033-021-06976-9. Epub 2022 Jan 6. Mol Biol Rep. 2022. PMID: 34988892 Review.
-
Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women.J Assist Reprod Genet. 1997 May;14(5):254-61. doi: 10.1007/BF02765826. J Assist Reprod Genet. 1997. PMID: 9147238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical